Cyclopharm Limited(AU:CYC)
A$0.46-0.01 (-3.16%)
AU:CYC
Cyclopharm Limited financials statements
A$0.46
At close:-0.01 (-3.16%)
Want to see AU:CYC full AI Analyst Report?
Cyclopharm Limited (CYC) Ratios
19 Followers
Cyclopharm Limited Ratios
AU:CYC's free cash flow for Q2 2026 was AU$-7.88M. For the 2026 fiscal year, AU:CYC's free cash flow was decreased by AU$-191.20K and operating cash flow was AU$-7.69M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.53 | 3.99 | 3.48 | 4.65 | 5.83 |
| Quick Ratio | 1.51 | 2.75 | 2.32 | 3.60 | 5.09 |
| Cash Ratio | 0.59 | 1.94 | 1.35 | 2.56 | 3.94 |
| Solvency Ratio | -0.81 | -0.64 | -0.28 | -0.44 | -0.34 |
| Operating Cash Flow Ratio | -1.54 | -1.19 | -0.83 | -0.84 | -0.22 |
| Short-Term Operating Cash Flow Coverage | -30.88 | -20.09 | -33.56 | -31.74 | -9.14 |
| Net Current Asset Value | AU$ 9.47M | AU$ 22.99M | AU$ 16.54M | AU$ 23.86M | AU$ 30.58M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.32 | 0.13 | 0.09 | 0.09 | 0.08 |
| Debt-to-Equity Ratio | 0.55 | 0.19 | 0.13 | 0.12 | 0.10 |
| Debt-to-Capital Ratio | 0.35 | 0.16 | 0.12 | 0.11 | 0.09 |
| Long-Term Debt-to-Capital Ratio | 0.21 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.70 | 1.45 | 1.42 | 1.36 | 1.29 |
| Debt Service Coverage Ratio | -13.29 | -14.62 | -10.10 | -14.81 | -24.23 |
| Interest Coverage Ratio | -29.03 | -44.96 | -24.37 | -27.38 | -72.04 |
| Debt to Market Cap | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.14 | 0.08 | 0.05 | 0.05 | 0.05 |
| Net Debt to EBITDA | -0.51 | 0.90 | 1.96 | 2.47 | 4.27 |
| Profitability Margins | |||||
| Gross Profit Margin | -4.51% | 65.04% | 61.06% | 25.58% | 18.09% |
| EBIT Margin | -56.25% | -52.68% | -18.12% | -31.87% | -36.99% |
| EBITDA Margin | -50.77% | -49.65% | -14.56% | -27.86% | -32.70% |
| Operating Profit Margin | -56.25% | -52.03% | -19.98% | -31.35% | -36.34% |
| Pretax Profit Margin | -55.24% | -47.41% | -15.91% | -33.02% | -37.49% |
| Net Profit Margin | -53.27% | -47.87% | -17.85% | -28.47% | -28.47% |
| Continuous Operations Profit Margin | -53.27% | -47.87% | -17.85% | -28.47% | -28.47% |
| Net Income Per EBT | 96.43% | 100.97% | 112.20% | 86.25% | 75.93% |
| EBT Per EBIT | 98.21% | 91.11% | 79.61% | 105.30% | 103.17% |
| Return on Assets (ROA) | -37.35% | -21.24% | -10.24% | -13.35% | -9.04% |
| Return on Equity (ROE) | -63.52% | -30.89% | -14.57% | -18.10% | -11.70% |
| Return on Capital Employed (ROCE) | -52.19% | -27.85% | -14.13% | -17.50% | -13.32% |
| Return on Invested Capital (ROIC) | -49.53% | -27.19% | -13.97% | -17.32% | -13.22% |
| Return on Tangible Assets | -39.65% | -23.47% | -11.70% | -15.29% | -10.19% |
| Earnings Yield | -15.96% | -8.07% | -2.63% | -6.08% | -3.43% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.76 | 3.67 | 3.34 | 3.01 | 2.20 |
| Payables Turnover | 8.32 | 2.54 | 7.19 | 3.93 | 6.67 |
| Inventory Turnover | 2.95 | 0.73 | 2.24 | 2.08 | 2.63 |
| Fixed Asset Turnover | 2.41 | 2.10 | 2.87 | 3.52 | 2.83 |
| Asset Turnover | 0.70 | 0.44 | 0.57 | 0.47 | 0.32 |
| Working Capital Turnover Ratio | 1.32 | 1.03 | 1.04 | 0.72 | 0.77 |
| Cash Conversion Cycle | 176.67 | 457.10 | 221.84 | 203.45 | 249.77 |
| Days of Sales Outstanding | 97.01 | 99.33 | 109.41 | 121.22 | 165.77 |
| Days of Inventory Outstanding | 123.54 | 501.61 | 163.17 | 175.18 | 138.72 |
| Days of Payables Outstanding | 43.88 | 143.83 | 50.74 | 92.94 | 54.72 |
| Operating Cycle | 220.55 | 600.94 | 272.58 | 296.39 | 304.49 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.16 | -0.12 | -0.08 | -0.07 | -0.02 |
| Free Cash Flow Per Share | -0.18 | -0.13 | -0.08 | -0.09 | -0.03 |
| Dividend Paid and CapEx Coverage Ratio | -8.70 | -12.94 | -5.06 | -2.74 | -0.80 |
| Capital Expenditure Coverage Ratio | -8.70 | -12.94 | -13.38 | -4.30 | -1.40 |
| Operating Cash Flow Coverage Ratio | -1.16 | -1.52 | -1.70 | -1.54 | -0.36 |
| Operating Cash Flow to Sales Ratio | -0.54 | -0.46 | -0.27 | -0.29 | -0.09 |
| Free Cash Flow Yield | -17.90% | -8.28% | -4.33% | -7.55% | -1.90% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -6.13 | -12.39 | -38.04 | -16.45 | -29.15 |
| Price-to-Sales (P/S) Ratio | 3.34 | 5.93 | 6.79 | 4.68 | 8.30 |
| Price-to-Book (P/B) Ratio | 3.98 | 3.83 | 5.54 | 2.98 | 3.41 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -5.59 | -12.07 | -23.12 | -13.24 | -52.64 |
| Price-to-Operating Cash Flow Ratio | -6.23 | -13.01 | -24.85 | -16.32 | -90.15 |
| Price-to-Earnings Growth (PEG) Ratio | -0.27 | -0.08 | 1.30 | -0.60 | 1.02 |
| Enterprise Value Multiple | -7.08 | -11.05 | -44.68 | -14.35 | -21.10 |
| Enterprise Value | 116.22M | 151.27M | 171.34M | 92.81M | 122.16M |
| EV to EBITDA | -7.08 | -11.05 | -44.68 | -14.35 | -21.10 |
| EV to Sales | 3.60 | 5.49 | 6.51 | 4.00 | 6.90 |
| EV to Free Cash Flow | -6.02 | -11.17 | -22.15 | -11.30 | -43.78 |
| EV to Operating Cash Flow | -6.71 | -12.03 | -23.81 | -13.93 | -74.97 |
| Tangible Book Value Per Share | 0.22 | 0.36 | 0.29 | 0.33 | 0.41 |
| Shareholders’ Equity Per Share | 0.25 | 0.42 | 0.35 | 0.40 | 0.48 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.04 | -0.01 | -0.12 | -0.08 | -0.10 |
| Revenue Per Share | 0.29 | 0.27 | 0.28 | 0.25 | 0.20 |
| Net Income Per Share | -0.16 | -0.13 | -0.05 | -0.07 | -0.06 |
| Tax Burden | 0.96 | 1.01 | 1.12 | 0.86 | 0.76 |
| Interest Burden | 0.98 | 0.90 | 0.88 | 1.04 | 1.01 |
| Research & Development to Revenue | 0.02 | 0.01 | 0.14 | 0.15 | 0.09 |
| SG&A to Revenue | 0.81 | 0.89 | 0.53 | 0.47 | 0.61 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.03 | 0.04 |
| Income Quality | 1.01 | 0.95 | 1.53 | 1.01 | 0.32 |
Currency in AUD

